Christopher Bird Announced as New Chief Medical Officer of BioPorto

Christopher Bird Announced as New Chief Medical Officer of BioPorto
share Share
Download PDF
The medical diagnostic company BioPorto has recently announced that it will be introducing Christopher Bird as the new Chief Medical Officer.

Bird joins BioPorto from his role at Roche Diagnostics as Head of Medical and Scientific Affairs in North America. After over 10 years with this medical and scientific affairs organisation, Christopher will now be responsible for leading the development of diagnostic products at BioPorto.

Image Credit: Proactive Investors

«« Creative Solutions for Staff Retention


The 2019 EHMA Annual Conference »»

Published on : Mon, 1 Jul 2019


BioPorto, Roche, Chief Medical Officer, Christopher Bird, Roche Diagnostics, Medical and Scientific Affairs, Head of Medical and Scientific Affairs, Bird, Christopher, medical diagnostic

Related Articles

Roche: Changes in the Board of Directors

Roche announced that at its December meeting the Board of Directors of Roche Holding Ltd has approved first proposals to the... Read more

Cardiff Oncology Announces Departure of Chief Medical Officer

Cardiff Oncology, Inc., a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a... Read more

Harbour BioMed Appoints Dr. Humphrey Gardner as Chief Medical Officer

Harbour BioMed has announced the appointment of Dr. Humphrey Gardner as Chief Medical Officer (CMO). Dr. Gardner will be responsible... Read more

BioPorto, Roche, Chief Medical Officer, Christopher Bird, Roche Diagnostics, Medical and Scientific Affairs, Head of Medical and Scientific Affairs, Bird, Christopher, medical diagnostic The medical diagnostic company BioPorto has recently announced that it will be introducing Christopher Bird as the new Chief Medical Officer.

No comment

Please login to leave a comment...